Aravind Palraj / X
Jul 22, 2025, 09:17
Decoding Antiphospholipid Syndrome: Why Triple Positivity Is a Red Flag for Thrombosis
Aravind Palraj, MD highlights a crucial message on his X page:
”Antiphospholipid antibodies (aPL) are key to diagnosing APS—but timing, type, and persistence matter.
Triple positive? Highest thrombosis risk.
Test smart. Interpret wisely.”
Want to dive deeper into Antiphospholipid Syndrome?
On Hemostasis Today, you can explore in-depth, clinically relevant, and first-hand academic knowledge on:
- Diagnostic strategies for APS
- Role of Lupus Anticoagulant, anticardiolipin, and β2-GPI antibodies
- Risk stratification and management approaches in triple-positive patients
- Anticoagulation dilemmas in APS
-
Aug 12, 2026, 06:55Alejandro González Veliz: A Good PCI is not Just about Opening the Artery
-
Aug 12, 2026, 06:39Abdulmalik Alnuqydan: Why Do We Transfuse RBCs Less Than 7 Days Old to Newborns?
-
Aug 12, 2026, 06:24Lucas Jae: How Mitochondria Sense Heme Scarcity to Regulate Heme and Globin Production
-
Aug 12, 2026, 06:09Luis Tam։ New CDC Global Health Security Funding Opportunities
-
Aug 12, 2026, 06:09Yan Leyfman: Curative Strategies and Precision Medicine in Sickle Cell Disease
-
Aug 12, 2026, 06:01Sophie He: Exploring Manufacturing Scalability and Cell Separation
-
Aug 12, 2026, 05:54Yuan Goessi: One Bleed Is One Too Many for a Lifetime of Haemophilia A
-
Aug 12, 2026, 05:47Shehab Mohamed: Philadelphia Negative MPNs in AYA vs Older Adults in Qatar
-
Aug 12, 2026, 05:35Burjor Langdana: Why Does Blast Traumatised Facial Tissue Keep Swelling and often Heal Badly